Paul Cox | IR |
Jeff Jonas | CEO |
Steve Kanes | Chief Medical Officer |
Kimi Iguchi | CFO |
Salveen Richter | Goldman Sachs |
Tazeen Ahmad | Bank of America Merrill Lynch |
Laura Chico | Raymond James |
Ritu Baral | Cowen & Company |
Cory Kasimov | JPMorgan |
Brian Abrahams | RBC Capital Markets |
Danielle Brill | Needham & Company |
Gary Nachman | BMO Capital Markets |
Adam Walsh | Stifel Nicolaus |
Tim Lugo | William Blair |
Good morning, and welcome to Sage Therapeutics Third Quarter 2017 Financial Results Conference Call. [Operator Instructions] This call is being webcast live on the Investors & Media section of Sage's Web site at sagerx.com. This call is the property of Sage Therapeutics and recording, reproduction or transmission of this call without the express written consent of Sage Therapeutics is strictly prohibited. Please note that this call is being recorded. I would now like to introduce Paul Cox, Head of Investor Relations at Sage.